WHO/SDE/WSH/03.04/69 English only 2-Phenylphenol in Drinking-water

Similar documents
WHO/SDE/WSH/03.04/77 English only Bentazone in Drinking-water

Permethrin in Drinking-water

Malathion in Drinking-water

Propanil in Drinking-water

WHO/SDE/WSH/03.04/95 English only Fenitrothion in Drinking-water

WHO/SDE/WSH/03.04/87 English only Chlorpyrifos in Drinking-water

WHO/SDE/WSH/07.01/9 English only Pyriproxyfen in Drinking-water: Use for Vector Control in Drinking-water Sources and Containers

WHO/SDE/WSH/03.04/70 English only 2,4-D in Drinking-water

WHO/SDE/WSH/07.01/4 English only Cyanogen Chloride in Drinking-water

Lindane in Drinking-water

WHO/SDE/WSH/04.08/64s. Trihalomethanes in drinking-water Summary statement

Trichlorobenzenes in Drinking-water

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. VOLUME 93 Carbon Black, Titanium Dioxide, and Talc

Part 2. Chemical and physical aspects

5.36 THIOPHANATE-METHYL (077)

Metolachlor in Drinking-water

biological agents volume 100 B A review of human carcinogens iarc monographs on the evaluation of carcinogenic risks to humans

Dithianon DITHIANON (180)

Dichloroacetic Acid in Drinking-water

Carbaryl in Drinking-water

Pesticides used for vector control in drinking-water sourcesand containers.

5.15 HEXYTHIAZOX (176)

Volume 10 Cervix Cancer Screening

5.17 PENTHIOPYRAD (253)

DIETARY RISK ASSESSMENT

Cycloxydim CYCLOXYDIM (179)

Codex MRL Setting and Harmonization. Yukiko Yamada, Ph.D.

Overheads. Complementary Feeding Counselling a training course. World Health Organization

Diquat in drinking-water

Folpet (Pesticides) Summary. Risk assessment report. Food Safety Commission of Japan. Conclusion in Brief

Hexachlorobutadiene in Drinking-water

Dicofol in Drinking-water

Dichlorvos DICHLORVOS (025)

CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES (AUGUST 2015)

Diflubenzuron in Drinking Water Use for Vector Control in Drinking Water Sources and Containers

1,2-Dichloroethene in Drinking-water

5.3 AZINPHOS METHYL (002)

5.24 TRIAZOLE FUNGICIDE METABOLITES

SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS Draft proposal for The International Pharmacopoeia (September 2010)

WHO/SDE/WSH/03.04/86 English only Chlorite and Chorate in Drinking-water

Residues of veterinary drugs in food

Styrene in Drinking-water

Revision of monograph in the 4 th Edition of The International Pharmacopoeia (August 2008)

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PAEDIATRIC RETINOL ORAL SOLUTION (August 2010)

WHO/SDE/WSH/03.04/94 English only Epichlorohydrin in Drinking-water

Cancer Incidence in Five Continents. Volume VIII

Multidrug-/ rifampicinresistant. (MDR/RR-TB): Update 2017

DRAFT PROPOSAL FOR THE INTERNATIONAL PHARMACOPOEIA: CARBAMAZEPINI COMPRESSI - CARBAMAZEPINE TABLETS

Captan (Pesticides) Summary. Risk assessment report. Food Safety Commission of Japan. Conclusion in Brief

Iron in Drinking-water

Chapter 6 Physical and chemical quality of drinking water

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE

MONITORING THE BUILDING BLOCKS OF HEALTH SYSTEMS: A HANDBOOK OF INDICATORS AND THEIR MEASUREMENT STRATEGIES

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON LAMIVUDINE TABLETS

DECISION GUIDANCE DOCUMENTS

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

aaaaaaaa Information Document on the Proposal to Reinstate Saccharin for Use as a Sweetener in Foods in Canada

Joint FAO/WHO Food Standards Programme Food and Agriculture Organization of the United Nations Lusaka, Zambia, 3-5 July 2002

Draft monograph for inclusion in. The International Pharmacopoeia. Dextromethorphani solutionum peroralum - Dextromethorphan oral solution

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

REVISED DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA RETINOL CONCENTRATE, OILY FORM. (August 2010)

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

PROPOSAL FOR REVISION OF MONOGRAPH PUBLISHED IN The International Pharmacopoeia: REVISION OF ph test ABACAVIR ORAL SOLUTION (JULY 2012)

ZIDOVUDINE, LAMIVUDINE AND ABACAVIR TABLETS Draft proposal for The International Pharmacopoeia (September 2006)

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE

5.17 METHOXYFENOZIDE (209)

MEDICAL SCIENCES - Vol.II -The Need For an International Approach The Role of FAO and WHO - Jorgen Schlundt and Kazuaki Miyagishima

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Nitrilotriacetic acid in Drinking-water

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

ABACAVIR SULFATE Proposal for revision of The International Pharmacopoeia (August 2012)

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA EFAVIRENZ, EMTRICITABINE AND TENOFOVIR TABLETS

:i iiii ï {:] liii M1!11111[.1i

PREPARATION AND SUBMISSION OF DATA DOSSIERS TO JMPR BY MANUFACTURERS. Dr Caroline A Harris and Cecilia Gaston Exponent International Ltd, UK

Regarding Establishment of a Uniform Limit in a Positive List System concerning Agricultural Chemicals Residues in Food etc.

PRINCIPLES FOR EVALUATING HEALTH RISKS IN CHILDREN ASSOCIATED WITH EXPOSURE TO CHEMICALS

Food additives. FAO guidelines on the structure and content of the document called "Chemical and Technical Assessment (CTA)" Rome, February 2003

GUIDANCE FOR SAMPLING ART CLINICS IN COUNTRIES COMBINING SURVEILLANCE OF PRE-TREATMENT HIV DRUG RESISTANCE AND ACQUIRED HIV DRUG RESISTANCE AT 12 AND

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

METHACRYLIC ACID CAS N :

Safety Data Sheet European Format

Safety Data Sheet European Format

Photo Book: Identify Signs of Illness

Table 1 Validation of analytical method used in the supervised trials

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Methoxychlor in Drinking-water

LEVONORGESTREL AND ETHINYLESTRADIOL TABLETS. (January 2012) DRAFT FOR COMMENT

EMTRICITABINE AND TENOFOVIR TABLETS

Boscalid BOSCALID (221)

5.24 METHOXYFENOZIDE (209)

Diabetes. Halt the diabetes epidemic

codex alimentarius commission

CYCLOSERINE Proposal for revision of The International Pharmacopoeia (August 2012)

Risk Assessment Report on Tris (nonylphenyl)phosphite (TNPP)

EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL

WHO/NMH/TFI/11.3. Warning about the dangers of tobacco. Executive summary. fresh and alive

5.8 DIMETHOMORPH (225)

BEST PRACTICES IN MICROPLANNING FOR CHILDREN OUT OF THE HOUSEHOLD: AN EXAMPLE FROM NORTHERN NIGERIA

Transcription:

WHO/SDE/WSH/03.04/69 English only 2-Phenylphenol in Drinking-water Background document for development of WHO Guidelines for Drinking-water Quality

World Health Organization 2003 All rights reserved. Publications of the World Health Organization can be obtained from Marketing and Dissemination, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to Publications, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The mention of specific companies or of certain manufacturers products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. The World Health Organization does not warrant that the information contained in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use

Preface One of the primary goals of WHO and its member states is that all people, whatever their stage of development and their social and economic conditions, have the right to have access to an adequate supply of safe drinking water. A major WHO function to achieve such goals is the responsibility to propose... regulations, and to make recommendations with respect to international health matters... The first WHO document dealing specifically with public drinking-water quality was published in 1958 as International Standards for Drinking-water. It was subsequently revised in 1963 and in 1971 under the same title. In 1984 1985, the first edition of the WHO Guidelines for Drinking-water Quality (GDWQ) was published in three volumes: Volume 1, Recommendations; Volume 2, Health criteria and other supporting information; and Volume 3, Surveillance and control of community supplies. Second editions of these volumes were published in 1993, 1996 and 1997, respectively. Addenda to Volumes 1 and 2 of the second edition were published in 1998, addressing selected chemicals. An addendum on microbiological aspects reviewing selected microorganisms was published in 2002. The GDWQ are subject to a rolling revision process. Through this process, microbial, chemical and radiological aspects of drinking-water are subject to periodic review, and documentation related to aspects of protection and control of public drinkingwater quality is accordingly prepared/updated. Since the first edition of the GDWQ, WHO has published information on health criteria and other supporting information to the GDWQ, describing the approaches used in deriving guideline values and presenting critical reviews and evaluations of the effects on human health of the substances or contaminants examined in drinkingwater. For each chemical contaminant or substance considered, a lead institution prepared a health criteria document evaluating the risks for human health from exposure to the particular chemical in drinking-water. Institutions from Canada, Denmark, Finland, France, Germany, Italy, Japan, Netherlands, Norway, Poland, Sweden, United Kingdom and United States of America prepared the requested health criteria documents. Under the responsibility of the coordinators for a group of chemicals considered in the guidelines, the draft health criteria documents were submitted to a number of scientific institutions and selected experts for peer review. Comments were taken into consideration by the coordinators and authors before the documents were submitted for final evaluation by the experts meetings. A final task force meeting reviewed the health risk assessments and public and peer review comments and, where appropriate, decided upon guideline values. During preparation of the third edition of the GDWQ, it was decided to include a public review via the world wide web in the process of development of the health criteria documents.

During the preparation of health criteria documents and at experts meetings, careful consideration was given to information available in previous risk assessments carried out by the International Programme on Chemical Safety, in its Environmental Health Criteria monographs and Concise International Chemical Assessment Documents, the International Agency for Research on Cancer, the joint FAO/WHO Meetings on Pesticide Residues and the joint FAO/WHO Expert Committee on Food Additives (which evaluates contaminants such as lead, cadmium, nitrate and nitrite, in addition to food additives). Further up-to-date information on the GDWQ and the process of their development is available on the WHO internet site and in the current edition of the GDWQ.

Acknowledgements The first draft of 2-Phenylphenol in Drinking-water, Background document for development of WHO Guidelines for Drinking-water Quality, was prepared by Dr P. Toft, Canada, to whom special thanks are due. The work of the following working group coordinators was crucial in the development of this document and others in the third edition: Mr J.K. Fawell, United Kingdom (Organic and inorganic constituents) Dr E. Ohanian, Environmental Protection Agency, USA (Disinfectants and disinfection by-products) Ms M. Giddings, Health Canada (Disinfectants and disinfection by-products) Dr P. Toft, Canada (Pesticides) Prof. Y. Magara, Hokkaido University, Japan (Analytical achievability) Mr P. Jackson, WRc-NSF, United Kingdom (Treatment achievability) The contribution of peer reviewers is greatly appreciated. The draft text was posted on the world wide web for comments from the public. The revised text and the comments were discussed at the Final Task Force Meeting for the third edition of the GDWQ, held on 31 March to 4 April 2003, at which time the present version was finalized. The input of those who provided comments and of participants in the meeting is gratefully reflected in the final text. The WHO coordinators were as follows: Dr J. Bartram, Coordinator, Water Sanitation and Health Programme, WHO Headquarters, and formerly WHO European Centre for Environmental Health Mr P. Callan, Water Sanitation and Health Programme, WHO Headquarters Mr H. Hashizume, Water Sanitation and Health Programme, WHO Headquarters Ms C. Vickers provided a liaison with the International Chemical Safety Programme, WHO Headquarters. Ms Marla Sheffer of Ottawa, Canada, was responsible for the scientific editing of the document. Many individuals from various countries contributed to the development of the GDWQ. The efforts of all who contributed to the preparation of this document and in particular those who provided peer or public domain review comment are greatly appreciated.

Acronyms and abbreviations used in the text ADI CARB CAS DNA FAO GEMS IARC JMPR LD 50 NOAEL WHO acceptable daily intake California Air Resources Board Chemical Abstracts Service deoxyribonucleic acid Food and Agriculture Organization of the United Nations Global Environment Monitoring System International Agency for Research on Cancer Joint FAO/WHO Meeting on Pesticide Residues median lethal dose no-observed-adverse-effect level World Health Organization

Table of contents 1. GENERAL DESCRIPTION...1 1.1 Identity...1 1.2 Physicochemical properties...1 1.3 Major uses...1 1.4 Environmental fate...1 2. ANALYTICAL METHODS...2 3. ENVIRONMENTAL LEVELS AND HUMAN EXPOSURE...2 3.1 Air...2 3.2 Food...2 4. KINETICS AND METABOLISM IN LABORATORY ANIMALS AND HUMANS...2 5. EFFECTS ON EXPERIMENTAL ANIMALS AND IN VITRO TEST SYSTEMS.3 6. CONCLUSIONS...5 7. REFERENCES...5

1. GENERAL DESCRIPTION 1.1 Identity CAS No.: 90-43-7 Molecular formula: C 12 H 10 O The chemical structure of 2-phenylphenol is shown below: 1.2 Physicochemical properties (CARB, 1997) Property Value Boiling point 280 284 C Melting point 55.5 57.5 C Density/specific gravity 1.213 at 25/4 C Vapour pressure 133 Pa at 100 C Solubility of 2-phenylphenol in water <0.1 g/litre at 20 C Solubility of sodium 2-phenylphenate in water 122 g dissolve in 100 ml water 1.3 Major uses 2-Phenylphenol is used as a disinfectant, bactericide and virucide. In agriculture, it is used in disinfecting fruits, vegetables and eggs. 2-Phenylphenol is also used as a general surface disinfectant in hospitals, nursing homes, veterinary hospitals, poultry farms, dairy farms, commercial laundries, barbershops and food processing plants. It is also used to sterilize hospital and veterinary equipment (CARB, 1997). 1.4 Environmental fate 2-Phenylphenol is readily degraded in surface waters and municipal waste mixtures, and the degradation is biologically mediated. In river water, radiolabelled 2- phenylphenol at concentrations ranging from 1.2 to 120 µg/litre was degraded to about 50% of the initial concentration in 1 week. The addition of mercuric chloride to inhibit biological activity reduced the decrease to only 10% after 30 days. In activated sludge, radiolabelled 2-phenylphenol at 9.6 mg/litre was degraded to 50% of the initial concentration in 24 h. 2-Phenylphenol therefore meets the criteria to be classified as readily biodegradable (FAO/WHO, 1999). Based on its vapour pressure, 2-phenylphenol can be expected to exist primarily in the gas phase in the ambient atmosphere, although a small percentage may be associated with the particulate phase. The calculated half-life and lifetime of 2-phenylphenol due to reaction with the hydroxyl radical are 10 h and 14 h, respectively (Atkinson, 1995). 1

2-PHENYLPHENOL IN DRINKING-WATER 2-Phenylphenol may also degrade very rapidly in night air by the reaction with nitrate radicals. 2. ANALYTICAL METHODS Numerous methods exist for the determination of 2-phenylphenol and sodium 2- phenylphenate. A gas liquid chromatographic method involves reflux distillation with hydrochloric acid and hexane. The distillate is extracted and analysed by gas liquid chromatography with a flame ionization detector and a capillary column. The limit of detection is 0.1 mg/kg (FAO/WHO, 1999). 3. ENVIRONMENTAL LEVELS AND HUMAN EXPOSURE 3.1 Air In surveys carried out in the USA in 1986 1988, indoor concentrations of 2-phenylphenol were moderately elevated. The mean indoor concentrations of 2- phenylphenol for homes in Massachusetts for spring and winter were 22.8 and 44.5 ng/m 3, respectively. The mean indoor concentrations for homes in Florida over three seasons ranged from 59.0 to 96.0 ng/m 3. In contrast, outdoor concentrations of 2-phenylphenol were much lower and ranged from below 0.05 to 1.6 ng/m 3 (CARB, 1997). 3.2 Food Median residues from supervised trials for one raw commodity and one processed commodity were used for a chronic dietary intake assessment. The International Estimated Daily Intakes for the five GEMS/Food regional diets, based on these trials, were all determined to be 0% of the ADI (see below). It was concluded that the intake of residues of 2-phenylphenol resulting from its uses that have been considered by JMPR is unlikely to present a public health concern (FAO/WHO, 1999). 4. KINETICS AND METABOLISM IN LABORATORY ANIMALS AND HUMANS 1 After oral administration to mice and rats, 2-phenylphenol and its sodium salt are rapidly and extensively absorbed (95%) and distributed. Excretion is also rapid in these species, being almost complete within 48 h, and occurs mainly in urine (about 90%) and in faeces (about 5%). Little radiolabel (<1%) is retained in organs and tissues, including the urinary bladder. After dermal application of 2-phenylphenol to humans, about 43% of the applied dose was absorbed through the skin, and about 58% was recovered in skin rinse and the protective enclosure. Most of the absorbed radiolabel was recovered in urine (99%), and only 1% was recovered in faeces. The absorption half-time was 10 h, and the elimination half-time was 0.8 h. The rapid excretion of the radiolabel into urine indicates that 2-phenylphenol is unlikely to 1 This section is taken from FAO/WHO (2000). 2

2-PHENYLPHENOL IN DRINKING-WATER accumulate in humans exposed repeatedly. The metabolic profiles of both compounds were similar in mice, rats and humans at the various doses tested. The main metabolic pathways are conjugation of 2-phenylphenol or hydroxylation at the 5 position of the phenol ring, followed by conjugation with glucuronide or sulfate. The parent compound was detected in only very small amounts (0.4%) in urine. The metabolic profile in plants raised no toxicological concern, since about 90% of the residue found in oranges and pears is 2-phenylphenol or its conjugates. 5. EFFECTS ON EXPERIMENTAL ANIMALS AND IN VITRO TEST SYSTEMS 2 2-Phenylphenol and its sodium salt have low acute toxicity in mice and rats treated orally, the LD 50 values ranging from 600 to 3500 mg/kg of body weight. WHO (2001) has classified 2-phenylphenol as unlikely to present an acute hazard in normal use. 2-Phenylphenol and its sodium salt caused severe dermal irritation in rabbits, and the sodium salt caused severe dermal irritation in humans. 2-Phenylphenol irritated the eye of rabbits, whereas the sodium salt caused only moderate ocular irritation. Neither substance caused delayed contact hypersensitivity in guinea-pigs or humans. In medium- and long-term tests for toxicity, the urinary bladder was regarded as the main toxicological target organ of both 2-phenylphenol and its sodium salt in male and female rats. At doses of 200 mg/kg of body weight per day and above, hyperplasia, papillomas and transitional cell carcinomas were seen with both compounds in male rats. Increased mitosis was observed in the bladder epithelium 3 days after the start of dosing, and thickening (i.e., simple hyperplasia) was seen at 14 days. In female rats, hyperplasia and papillomas were observed, but to a far lower degree than in males. In male and female mice, the liver was the primary target organ. Increased relative liver weights and an increased incidence of hepatocellular adenomas were seen with 2-phenylphenol at doses of 500 mg/kg of body weight per day and above. Reduced body weight gain was a common finding in mice and rats. In 90-day studies, the NOAELs for 2-phenylphenol were 6300 mg/kg, equal to 760 mg/kg of body weight per day, in rats and 300 mg/kg of body weight per day (the highest dose tested for up to 1 year) in dogs. The NOAEL for the sodium salt was 5000 mg/kg, equivalent to 550 mg/kg of body weight per day, in mice and 2500 mg/kg, equal to 180 mg/kg of body weight per day, in rats. In a 1-year study of toxicity, the NOAEL for 2-phenylphenol was 800 mg/kg, equal to 39 mg/kg of body weight per day, in rats. In 2-year studies of carcinogenicity, the NOAEL for 2- phenylphenol was 250 mg/kg of body weight per day in mice and 800 mg/kg, equal to 39 mg/kg of body weight per day, in rats. In 2-year carcinogenicity studies with the sodium salt, the NOAEL for carcinogenicity was 20 000 mg/kg, equal to 3000 mg/kg of body weight per day, in mice and 2500 mg/kg, equivalent to 95 mg/kg of body weight per day, in rats. The Meeting concluded that both 2-phenylphenol and its 2 This section is taken from FAO/WHO (2000). 3

2-PHENYLPHENOL IN DRINKING-WATER sodium salt are carcinogenic in male rats and that 2-phenylphenol is carcinogenic in male mice. 2-Phenylphenol has been more extensively tested for genotoxic activity than its sodium salt. Within that limitation, the results for the two compounds were similar. Data regarding covalent binding to DNA in the urinary bladder of rats dosed with either compound were conflicting. 2-Phenylphenol induced chromosomal aberrations in cultured mammalian cells, but negative results were obtained in vivo. The Meeting concluded that there are unresolved questions about the genotoxic potential of 2- phenylphenol. Several studies have been conducted to elucidate the mechanism of the carcinogenic action of 2-phenylphenol and its sodium salt on the male rat urinary bladder, since neither compound has a carcinogenic effect on the urinary bladder of female rats or in mice, guinea-pigs or hamsters of either sex. No clear mechanisms have been found, although raising the urinary ph or sodium concentration has a promoting effect. There was some evidence from studies with the sodium salt that initial irritation followed by hyperplasia might be involved in the bladder carcinogenicity in male rats. In addition, 32 P-postlabelling showed binding of 2-phenylphenol and its sodium salt to DNA in the male rat urinary bladder in some studies, but not in others. The genotoxicity of the metabolites phenylhydroquinone and dihydroxybiphenyl appears to be similar to that of the parent molecules. The Meeting concluded that the urinary bladder tumours observed in male rats and the liver tumours observed in male mice exposed to 2-phenylphenol are threshold phenomena that are species- and sex-specific, and that 2-phenylphenol is therefore unlikely to represent a carcinogenic risk to humans. In coming to this conclusion, the Meeting was aware that a working group convened by IARC had classified 2- phenylphenol, sodium salt, in Group 2B (possibly carcinogenic to humans) and 2- phenylphenol in Group 3 (not classifiable as to its carcinogenicity to humans). The Meeting noted, however, that the IARC classification is based on hazard identification, not on risk assessment, and is furthermore limited to published literature, with the exclusion of unpublished studies on toxicity and carcinogenicity. In two two-generation studies of reproductive toxicity in rats, 2-phenylphenol had no reproductive toxicity, even at 460 mg/kg of body weight per day, the highest dose tested. The overall NOAEL for carcinogenicity was 92 mg/kg of body weight per day, since urinary bladder tumours were found in male rats at doses of 120 mg/kg of body weight per day and above. In a study of developmental toxicity in mice with 2-phenylphenol and its sodium salt, the NOAELs for 2-phenylphenol were below 1500 mg/kg of body weight per day (lowest dose tested) for maternal toxicity and fetotoxicity and 2100 mg/kg of body weight per day (highest dose tested) for teratogenicity. The NOAELs for the sodium salt were below 100 mg/kg of body weight per day (lowest dose tested) for maternal toxicity, 100 mg/kg of body weight per day for fetotoxicity and 400 mg/kg of body weight per day (highest dose tested) for teratogenicity. In two studies of 4

2-PHENYLPHENOL IN DRINKING-WATER developmental toxicity in rats, the overall NOAELs for 2-phenylphenol were 150 mg/kg of body weight per day for maternal toxicity, 300 mg/kg of body weight per day for fetotoxicity and 700 mg/kg of body weight per day (highest dose tested) for teratogenicity. In two studies of developmental toxicity in rabbits, the overall NOAELs for 2-phenylphenol were 100 mg/kg of body weight per day for maternal toxicity, 500 mg/kg of body weight per day for fetotoxicity and 750 mg/kg of body weight per day (highest dose tested) for teratogenicity. 6. CONCLUSIONS The Meeting established an ADI of 0.4 mg/kg of body weight for 2-phenylphenol, on the basis of the NOAEL of 39 mg/kg of body weight per day in the 2-year study of toxicity (based on decreased body weight gain and hyperplasia of the urinary bladder) and carcinogenicity of the urinary bladder in male rats and a safety factor of 100. A health-based value of 1 mg/litre (rounded value) can be calculated from the ADI of 0.4 mg/kg of body weight, based on an allocation of 10% of the ADI to drinkingwater. However, 2-phenylphenol usually occurs at concentrations in drinking-water well below those at which toxic effects can be expected to be observed. Under usual conditions, therefore, the presence of 2-phenylphenol in drinking-water is unlikely to represent a hazard to human health. For this reason, the establishment of a numerical guideline value for 2-phenylphenol is not deemed necessary. 7. REFERENCES Atkinson R (1995) Personal review of the Air Resources Board s Toxic Air Contaminant Identification List compounds. Riverside, CA, University of California. CARB (1997) Toxic Air Contaminant Fact Sheet 2-Phenylphenol. Sacramento, CA, California Air Resources Board. Available at http://www.arb.ca.gov/toxics/tac/factshts/2phnylph.pdf. FAO/WHO (1999) Pesticide residues in food 1999. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues in Food and the Environment and the WHO Core Assessment Group (FAO Plant Production and Protection Paper 153). FAO/WHO (2000) Pesticide residues in food 1999 evaluations. Part II Toxicological. Geneva, World Health Organization, Joint FAO/WHO Meeting on Pesticide Residues. WHO (2001) The WHO recommended classification of pesticides by hazard and guidelines to classification 2000 2002. Geneva, World Health Organization, International Programme on Chemical Safety (WHO/PCS/01.5). 5